A detailed history of Ikarian Capital, LLC transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 52,238 shares of NUVL stock, worth $4.38 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
52,238
Previous 151,601 65.54%
Holding current value
$4.38 Million
Previous $11.5 Million 53.54%
% of portfolio
0.93%
Previous 4.65%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.44 - $112.17 $6.7 Million - $11.1 Million
-99,363 Reduced 65.54%
52,238 $5.34 Million
Q2 2024

Aug 14, 2024

BUY
$62.76 - $81.61 $3.14 Million - $4.08 Million
50,000 Added 49.21%
151,601 $11.5 Million
Q1 2024

May 15, 2024

SELL
$72.35 - $88.99 $11.3 Million - $13.9 Million
-156,541 Reduced 60.64%
101,601 $7.63 Million
Q4 2023

Feb 14, 2024

SELL
$42.42 - $80.28 $843,818 - $1.6 Million
-19,892 Reduced 7.15%
258,142 $19 Million
Q3 2023

Nov 14, 2023

BUY
$39.12 - $49.85 $206,631 - $263,307
5,282 Added 1.94%
278,034 $12.8 Million
Q2 2023

Aug 14, 2023

BUY
$23.58 - $44.68 $6.43 Million - $12.2 Million
272,752 New
272,752 $11.5 Million

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $3.6B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.